Award News oronto, Ontario – TheNewswire – November 24, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that Ventripoint will be highlighted as one of Life Sciences Ontario (LSO) 2021 Success Stories (https://lifesciencesontario.ca/reports-and-publications/).The LSO campaign aims to highlight companies and institutions that are creating innovative solutions in the life science sector. The LSO is a member-funded, non-for-profit organization that works to advance advocacy and policy work, education and networking events, and support services for the life sciences sector. As part of the campaign, Ventripoint’s story will be distributed at LSO Queens Park meetings where MPPs are engaged on future policy development as an example of innovation that improves healthcare in a more cost-effective manner.
"Ontario's life sciences industry is dedicated to bringing new innovations to improve the lives of all Canadians. Success stories, like Ventripoint Diagnostics, show how scientific discoveries can be turned into real-world solutions; while creating jobs and prosperity here in Ontario," Dr. Jason Field, CEO, and President of Life Sciences Ontario.
The VMS+ is the first cost effective and accurate system for measuring the function all four chambers of the heart. This initiative will help to bring brand awareness and spread the word about Ventripoint’s innovative solution to improve cardiac diagnosis for everyone worldwide and especially for children.
About Life Sciences Ontario
LSO’s mission is to foster commercial success for Ontario’s life sciences sector through advocacy and education, and promoting the industry locally, nationally, and internationally. The LSO works to increase the profile of Ontario’s Life Sciences sector to secure economic and social prosperity. The organization’s education around successful companies within the sector facilitates will support the growth and development of the life science sector.